Elanco Animal Health (ELAN) Accumulated Expenses (2017 - 2025)
Elanco Animal Health (ELAN) posted Accumulated Expenses of $206.0 million for Q4 2025, up 16.38% sequentially from $177.0 million in Q4 2024, and up 16.38% YoY from $177.0 million in Q4 2024.
Elanco Animal Health (ELAN) Accumulated Expenses (2017 - 2025) Analysis & Trends
Elanco Animal Health has reported Accumulated Expenses for 9 years, with the latest figure at $206.0 million in Q4 2025.
- Quarterly Accumulated Expenses rose 16.38% year-over-year to $206.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $206.0 million (up 16.38% YoY) and the FY2025 annual result came in at $206.0 million, up 16.38% from the prior year.
- Accumulated Expenses improved to $206.0 million in Q4 2025 per ELAN's latest filing, from $177.0 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $206.0 million in Q4 2025 and troughed at $110.0 million in Q1 2023.
- A 5-year average of $144.8 million and a median of $141.0 million in 2022 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2021 and 2022: Accumulated Expenses soared 116.78% in 2021, then dropped 21.08% in 2022.
- Over 5 years, Accumulated Expenses stood at $185.0 million in 2021, then slipped by 21.08% to $146.0 million in 2022, then grew by 7.53% to $157.0 million in 2023, then increased by 12.74% to $177.0 million in 2024, then increased by 16.38% to $206.0 million in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $206.0 million, $177.0 million, and $157.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 206.00 Mn |
| Dec 31, 2024 | 177.00 Mn |
| Dec 31, 2023 | 157.00 Mn |
| Mar 31, 2023 | 110.00 Mn |
| Dec 31, 2022 | 146.00 Mn |
| Sep 30, 2022 | 136.00 Mn |
| Jun 30, 2022 | 113.00 Mn |
| Mar 31, 2022 | 111.00 Mn |
| Dec 31, 2021 | 185.00 Mn |
| Sep 30, 2021 | 159.00 Mn |
| Jun 30, 2021 | 124.00 Mn |
| Mar 31, 2021 | 114.00 Mn |
| Dec 31, 2020 | 144.00 Mn |
| Sep 30, 2020 | 139.90 Mn |
| Jun 30, 2020 | 57.20 Mn |
| Mar 31, 2020 | 56.20 Mn |
| Dec 31, 2019 | 99.60 Mn |
| Sep 30, 2019 | 88.80 Mn |
| Jun 30, 2019 | 67.30 Mn |
| Mar 31, 2019 | 64.20 Mn |